Ramsey is approved to sell rosuvastatin in Canada
-
Last Update: 2012-04-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: China Council for the promotion of drugs 2012-04-01 Reuters reported that lumberger Canada Pharmaceutical Co., Ltd or the wholly-owned subsidiary of lumberger laboratories Co., Ltd rhodwell Park Cancer Research Institute announced that the health department of Canada approved it to produce and sell lumberger rosuvastatin tablets for the medical system of Canada Rosuvastatin is an HMG CoA reductase inhibitor (cholesterol lowering drug) Crestorin's sales in Canada were $742.2 million "The development of rosuvastatin tablets has been completed and it will be produced in an Indian plant by Lambert laboratories Ltd approved by the Ministry of health of Canada We expect to provide rosuvastatin tablets to various sales channels after April 2 to meet the market demand " Paul Drake, President and general manager of the Rockwell Park Cancer Institute Original link: http://www.rttnews.com/1851713/ranbaxy-objects-approval-to-market-ran-rosuvastatin-in-canada-quick-facts.aspx
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
